An open-label early access phase IIIb study of trifluridine / tipiracil (S 95005/TAS-102) in patients with a pretreated metastatic colorectal cancer.
Phase of Trial: Phase III
Latest Information Update: 05 Oct 2017
At a glance
- Drugs Tipiracil/trifluridine (Primary)
- Indications Colorectal cancer
- Focus Adverse reactions
- Sponsors Servier
- 04 Jan 2017 This trial has been discontinued in Spain as per European Clinical Trials Database record.
- 06 Oct 2016 New trial record